Drug Discovery
Projects bridges AI-driven target prioritization with precision experimental pipelines to uncover novel therapeutics. Leveraging structural bioinformatics and high-throughput virtual screening, the platform computationally evaluates millions of compounds against metagenes—AI-identified genes critical to disease mechanisms (e.g., cancer progression, antimicrobial resistance).
Jan 13, 2024
